Pediatrician warns Puerto Rico about risks of gender affirmation therapies for minors
May 26, 2021 | Senate, Committees, Legislative, Puerto Rico, International
This article was created by AI summarizing key points discussed. AI makes mistakes, so for full details and context, please refer to the video of the full meeting. Please report any errors so we can fix them. Report an error »
In a recent meeting of the Comisión de Iniciativas Comunitarias, health professionals Dr. Rosalina Valcarcel and Marta Carabayo raised critical concerns regarding the treatment of gender dysphoria in minors. Their discussions highlighted the complexities surrounding gender identity development and the potential risks associated with medical interventions.
Dr. Valcarcel emphasized that during the psychosexual development phase, particularly around puberty, many children experience a natural period of gender confusion. She noted that a significant percentage of children ultimately accept their biological sex after this phase, suggesting that intervention during this time may not be advisable. Instead, she advocated for a supportive approach that allows for observation and understanding rather than immediate medical treatment.
A key point of contention was the proposed amendment to Article 106, which seeks to define conversion therapy. Dr. Valcarcel warned that this could inadvertently limit access to psychological services for adolescents and their families seeking support during this confusing time. She expressed concern that mental health professionals might hesitate to provide necessary care due to fears of legal repercussions.
The discussion also touched on the implications of gender affirmation therapies, including the use of puberty blockers and cross-sex hormones. Dr. Valcarcel raised alarms about the irreversible effects these treatments could have on young individuals, particularly if they later decide to transition. She cited a notable case from the UK involving a young woman who regretted her transition, highlighting the importance of informed consent and the ability of minors to fully understand the long-term consequences of such decisions.
Furthermore, Dr. Valcarcel shared a recent clinical case of a 21-year-old who experienced severe mental health issues, including a suicide attempt, after undergoing hormone therapy. This case underscored the potential dangers associated with medical interventions for gender dysphoria, particularly in the context of existing mental health challenges.
The meeting concluded with Dr. Valcarcel urging lawmakers to consider the ethical implications of imposing experimental treatments on adolescents who may not possess the cognitive maturity to make such significant decisions. She called for a careful examination of public policies that govern healthcare practices for minors, advocating for the protection of children's well-being and the preservation of their natural developmental processes.
As discussions continue, the committee faces the challenge of balancing the rights and needs of transgender youth with the imperative to ensure their safety and mental health. The outcomes of these deliberations could have lasting impacts on healthcare practices and policies in Puerto Rico.
Dr. Valcarcel emphasized that during the psychosexual development phase, particularly around puberty, many children experience a natural period of gender confusion. She noted that a significant percentage of children ultimately accept their biological sex after this phase, suggesting that intervention during this time may not be advisable. Instead, she advocated for a supportive approach that allows for observation and understanding rather than immediate medical treatment.
A key point of contention was the proposed amendment to Article 106, which seeks to define conversion therapy. Dr. Valcarcel warned that this could inadvertently limit access to psychological services for adolescents and their families seeking support during this confusing time. She expressed concern that mental health professionals might hesitate to provide necessary care due to fears of legal repercussions.
The discussion also touched on the implications of gender affirmation therapies, including the use of puberty blockers and cross-sex hormones. Dr. Valcarcel raised alarms about the irreversible effects these treatments could have on young individuals, particularly if they later decide to transition. She cited a notable case from the UK involving a young woman who regretted her transition, highlighting the importance of informed consent and the ability of minors to fully understand the long-term consequences of such decisions.
Furthermore, Dr. Valcarcel shared a recent clinical case of a 21-year-old who experienced severe mental health issues, including a suicide attempt, after undergoing hormone therapy. This case underscored the potential dangers associated with medical interventions for gender dysphoria, particularly in the context of existing mental health challenges.
The meeting concluded with Dr. Valcarcel urging lawmakers to consider the ethical implications of imposing experimental treatments on adolescents who may not possess the cognitive maturity to make such significant decisions. She called for a careful examination of public policies that govern healthcare practices for minors, advocating for the protection of children's well-being and the preservation of their natural developmental processes.
As discussions continue, the committee faces the challenge of balancing the rights and needs of transgender youth with the imperative to ensure their safety and mental health. The outcomes of these deliberations could have lasting impacts on healthcare practices and policies in Puerto Rico.
View the Full Meeting & All Its Details
This article offers just a summary. Unlock complete video, transcripts, and insights as a Founder Member.
✓
Watch full, unedited meeting videos
✓
Search every word spoken in unlimited transcripts
✓
AI summaries & real-time alerts (all government levels)
✓
Permanent access to expanding government content
30-day money-back guarantee
